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Infections in HIV-exposed uninfected infants:
Under-appreciated but a growing concern
M.F. Cotton
University of Stellenbosch, Cape Town, South Africa
With improving measures to prevent vertical transmission of
HIV and an expanding population of young adults acquiring HIV,
the population of HIV-exposed uninfected (HEU) infants is increas-
ing. This group is at higher risk for infectious morbidity than the
general population. Obvious reasons include a higher prevalence of
infectiousdiseases suchas tuberculosis in thehousehold and illness
in the parents affecting care & family integrity. HIV exposure, itself
might affect the immune system and formula feeding can exacer-
bate gastro-intestinal infections. Antiretroviral exposure in utero is
occasionally associated with neurodevelopmental delay.
Emerging data on infections in HEU children will be presented.
We will also discuss our own increasing awareness of this prob-
lem. The spectrum of disease can be similar to that seen in
HIV-infected children and includes Pneumocystis pneumonia and
cytomegalovirus-associated colitis.1-4
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Second- and third-line treatment for pediatric
patients failing ART
C. Giaquinto
University of Padua, Padua, Italy
Recommending potent and effective second-line regimens for
infants and children is especially difﬁcult because of the current
lack of experience in resource-limited settings and the limited for-
mulations available. This highlights the importance of choosing
potent and effective ﬁrst-line regimens and ensuring their dura-
bility and effectiveness by optimizing adherence.
The 2010 WHO guidelines recommended a regimen based on a
PI boosted with RTV and combined with two NRTIs as the second-
line treatment for children who fail a regimen of two NRTIs plus
an NNRTI. For infants and young children exposed to an NNRTI
as part of PMTCT interventions and starting a PI-based regimen
in ﬁrst-line ART, the recommendation for second-line was to use
two new NRTIs and an NNRTI, as this was the only new drug class
available.
The 2013 WHO guidelines recommend as ﬁrst line therapy a
PI containing regimen. Therefore after failure of ﬁrst line children
should switch to an NNRTI based regimen including EFV if older
than 3 years of age.
Newdrugs including integrase and ﬁxed dose combination have
been introduced in the market in the developed worlds and expe-
rience on their use is growing in developing countries settings.
Validation studies to assess these new combinations are critical to
ensure future effective alternatives. Innovative second-line strate-
gies such as PI+integrase or induction and maintenance using PI/r
monotherapy among children should also be investigated.
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The emerging challenge of managing
HIV-infected adolescents
R. Ferrand
London School of Hygiene and Tropical Medicine,
London, United Kingdom
Worldwide, more than three million children are infected with
human immunodeﬁciencyvirus (HIV), approximately 90%ofwhom
live in sub-Saharan Africa. There has been a remarkable expansion
in access topaediatricARTglobally since2004, resulting in substan-
tial decline in mortality rates in HIV-infected children. As the HIV
epidemic matures, interventions to prevent mother-to-child HIV
transmission (PMTCT) and antiretroviral therapy (ART) is scaled up,
the burden of paediatric HIV infection is shifting to adolescents.
The growing population of perinatally HIV-infected adolescents
within this region presents not only unprecedented challenges,
but also opportunities to learn about managing chronic disease.
Adolescents who have grown up with HIV present signiﬁcant chal-
lenges to HIV care programmes. Some of the unique features that
characterise HIV infection in adolescence are considered. Long-
standing HIV infection acquired when the immune system is not
developed results in distinctive chronic clinical complications that
cause severe morbidity. There is limited understanding of the
pathogenesis of these conditions. As well as dealing with chronic
illness, HIV-infected adolescents have to confront psychosocial
issues, maintain adherence to drugs, and learn to negotiate sexual
relationships, while undergoing rapid physical and psychological
development. Context-speciﬁc strategies for earlier identiﬁcation
and prompt linkage to care of HIV-infected adolescents need to
be developed. Clinical HIV care should integrate age-appropriate
sexual and reproductive health, psychological, educational and
social services. Healthcare workers will need to be trained to
recognise and manage the needs of this age-group so that the
increasing numbers of children surviving to adolescence can access
